Navinta Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NAVINTA LLC, and what generic and branded alternatives to NAVINTA LLC drugs are available?
NAVINTA LLC has sixteen approved drugs.
Summary for Navinta Llc
| US Patents: | 0 |
| Tradenames: | 15 |
| Ingredients: | 15 |
| NDAs: | 16 |
| Drug Master File Entries: | 25 |
Drugs and US Patents for Navinta Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Navinta Llc | SODIUM PHENYLACETATE AND SODIUM BENZOATE | sodium benzoate; sodium phenylacetate | SOLUTION;INTRAVENOUS | 205880-001 | Aug 4, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Navinta Llc | HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride | INJECTABLE;INJECTION | 202938-001 | Mar 28, 2013 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Navinta Llc | FOMEPIZOLE | fomepizole | INJECTABLE;INJECTION | 078537-001 | Mar 6, 2008 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Navinta Llc | FAMOTIDINE | famotidine | FOR SUSPENSION;ORAL | 091020-001 | May 27, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Navinta Llc | RIBAVIRIN | ribavirin | FOR SOLUTION;INHALATION | 207366-001 | Oct 6, 2016 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
